Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLATIRAMER Cause C-reactive protein increased? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of C-reactive protein increased have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.0% of all adverse event reports for GLATIRAMER.

13
Reports of C-reactive protein increased with GLATIRAMER
0.0%
of all GLATIRAMER reports
0
Deaths
8
Hospitalizations

How Dangerous Is C-reactive protein increased From GLATIRAMER?

Of the 13 reports, 8 (61.5%) required hospitalization, and 2 (15.4%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does GLATIRAMER Cause?

Injection site pain (5,003) Multiple sclerosis relapse (3,695) Drug ineffective (3,321) Injection site reaction (3,317) Multiple sclerosis (2,596) Injection site erythema (2,560) Fatigue (2,408) Dyspnoea (2,364) Injection site mass (2,172) Injection site swelling (1,836)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which GLATIRAMER Alternatives Have Lower C-reactive protein increased Risk?

GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR GLATIRAMER vs GLEEVEC GLATIRAMER vs GLICLAZIDE GLATIRAMER vs GLIMEPIRIDE GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE

Related Pages

GLATIRAMER Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased GLATIRAMER Demographics